Skip to content

Drug interactions

Mavacamten + Olanzapine

Severity: Minor

Mavacamten and Olanzapine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Mavacamten is metabolized mainly by CYP2C19, with a contribution from CYP3A4. Olanzapine is not an established CYP2C19 inhibitor, so any rise in mavacamten exposure is unlikely to be meaningful.

What this interaction means in plain words

Mavacamten and Olanzapine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Mavacamten belongs to Cardiovascular; Olanzapine belongs to Central Nervous System.

Evidence level: Low

Why it happens

A theoretical inhibitory effect on CYP2C19 that is not clinically established.

What to do

No empirical dose change is needed. Follow the standard mavacamten echocardiographic monitoring of LVEF.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Mavacamten and Olanzapine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Mavacamten with Olanzapine?

MediHelp rates the interaction as minor. Mavacamten and Olanzapine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Mavacamten is metabolized mainly by CYP2C19, with a contribution from CYP3A4. Olanzapine is not an established CYP2C19 inhibitor, so any rise in mavacamten exposure is unlikely to be meaningful.

How serious is the interaction between Mavacamten and Olanzapine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No empirical dose change is needed. Follow the standard mavacamten echocardiographic monitoring of LVEF.

What other medicines interact with Olanzapine?

MediHelp also lists interactions of Olanzapine with, for example, Amisulpride, Amoxapine, Apomorphine. The full list is on the Olanzapine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in